









市场行情
/
股票
/
nasdaq-neo
/

Neogenomics Inc

NEO

12.280USD

-0.020-0.16%

收盘 12/26, 16:00（美东）报价延迟15分钟

1.58B总市值

亏损市盈率 TTM



Neogenomics Inc

12.280

-0.020-0.16%

概览公司财务分析

概览

公司

财务

分析

关于 Neogenomics Inc 公司

NeoGenomics, Inc. is a cancer diagnostics company specializing in cancer genetics testing and information services. The Company offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing; interpretation and consultative services; molecular and NGS testing; comprehensive technical and professional services offering; clinical trials and research; validation laboratory services, and oncology data solutions. It operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics (karyotype analysis), Fluorescence In-Situ Hybridization (FISH), Flow cytometry, and others.

Neogenomics Inc简介



公司代码NEO

公司名称Neogenomics Inc

上市日期Dec 10, 2012

CEOZook (Antony P)

员工数量2200

证券类型Ordinary Share

年结日Dec 10

公司地址9490 Neogenomics Way

城市FORT MYERS

上市交易所NASDAQ OMX - NASDAQ BASIC

国家United States of America

邮编33912

电话12397680600

网址https://neogenomics.com/

公司代码NEO

上市日期Dec 10, 2012

CEOZook (Antony P)

Neogenomics Inc公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Jeffrey Scott (Jeff) Sherman

Chief Financial Officer

174.72K

-6.40%

Mr. Warren Stone

President, Chief Operating Officer

99.50K

-8.10%

Mr. Stephen Michael Kanovsky

Independent Director

52.34K

+30.57%

Dr. Neil Gunn

Independent Director

28.10K

+77.33%

Ms. Felicia Williams

Independent Director

7.16K

Ms. Lynn A. Tetrault, J.D.

Independent Chairman of the Board

Dr. Alison L. Hannah, M.D.

Independent Director

Mr. Gregory Aunan

Chief Accounting Officer

Ms. Alicia Olivo

Executive Vice President, General Counsel & Business Development

Mr. Michael A. Kelly

Lead Independent Director

名称

名称/职务

职务

持股

持股变动

Mr. Jeffrey Scott (Jeff) Sherman

Chief Financial Officer

174.72K

-6.40%

Mr. Warren Stone

President, Chief Operating Officer

99.50K

-8.10%

Mr. Stephen Michael Kanovsky

Independent Director

52.34K

+30.57%

Dr. Neil Gunn

Independent Director

28.10K

+77.33%

Ms. Felicia Williams

Independent Director

7.16K

Ms. Lynn A. Tetrault, J.D.

Independent Chairman of the Board

收入明细

单位: USD更新时间: 10月6日周一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Clinical Services-Client direct billing

131.16M

72.33%

Clinical Services-Commercial Insurance

28.77M

15.86%

Clinical Services-Medicare and Medicaid

21.39M

11.79%

Clinical Services-Self-Pay

20.00K

0.01%

由于公司未披露，未能获取相关数据

业务

地区

业务USD

名称

营收

占比

Clinical Services-Client direct billing

131.16M

72.33%

Clinical Services-Commercial Insurance

28.77M

15.86%

Clinical Services-Medicare and Medicaid

21.39M

11.79%

Clinical Services-Self-Pay

20.00K

0.01%

股东统计

更新时间: 11月17日周一

持股股东

股东类型

持股股东

占比

BlackRock Institutional Trust Company, N.A.

13.59%

The Vanguard Group, Inc.

10.72%

First Light Asset Management, LLC

7.67%

Greenhouse Funds LLLP

6.35%

Millennium Management LLC

5.01%

其他

56.65%

持股股东

占比

BlackRock Institutional Trust Company, N.A.

13.59%

The Vanguard Group, Inc.

10.72%

First Light Asset Management, LLC

7.67%

Greenhouse Funds LLLP

6.35%

Millennium Management LLC

5.01%

其他

56.65%

股东类型

持股股东

占比

Investment Advisor

44.58%

Investment Advisor/Hedge Fund

29.42%

Hedge Fund

23.57%

Research Firm

2.99%

Pension Fund

1.27%

Individual Investor

1.26%

Bank and Trust

0.58%

Sovereign Wealth Fund

0.09%

Family Office

0.04%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

568

127.88M

98.83%

-9.78M

2025Q2

571

126.82M

98.17%

-12.95M

2025Q1

596

131.44M

102.13%

-4.71M

2024Q4

585

127.59M

99.32%

-7.82M

2024Q3

589

129.38M

100.96%

-8.76M

2024Q2

597

131.21M

102.74%

-9.36M

2024Q1

633

132.83M

104.04%

-13.13M

2023Q4

672

130.90M

102.70%

-12.18M

2023Q3

691

124.98M

98.00%

-16.78M

2023Q2

691

121.76M

95.45%

-23.63M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

BlackRock Institutional Trust Company, N.A.

17.77M

13.76%

-516.86K

-2.83%

Jun 30, 2025

The Vanguard Group, Inc.

14.10M

10.92%

-126.36K

-0.89%

Jun 30, 2025

First Light Asset Management, LLC

6.85M

5.3%

+803.61K

+13.30%

Jun 30, 2025

Greenhouse Funds LLLP

7.43M

5.75%

+2.72M

+57.83%

Jun 30, 2025

Millennium Management LLC

3.32M

2.57%

-3.40M

-50.63%

Jun 30, 2025

State Street Investment Management (US)

5.11M

3.96%

+21.77K

+0.43%

Jun 30, 2025

Deerfield Management Company, L.P.

2.15M

1.66%

+2.15M

Jun 30, 2025

Dimensional Fund Advisors, L.P.

4.29M

3.32%

+448.53K

+11.66%

Jun 30, 2025

Schroder Investment Management North America Inc.

3.72M

2.88%

-587.33K

-13.63%

Jun 30, 2025

持股ETF



更新时间: 12月6日周六

机构名称

占比

State Street SPDR S&P Health Care Services ETF

2.38%

Invesco S&P SmallCap Health Care ETF

0.77%

First Trust Nasdaq Lux Digi Health Solutions ETF

0.5%

Inspire Small/Mid Cap ESG ETF

0.32%

iShares U.S. Healthcare Providers ETF

0.2%

Invesco S&P SmallCap 600 QVM Multi-factor ETF

0.14%

iShares S&P Small-Cap 600 Value ETF

0.12%

Nuveen ESG Small-Cap ETF

0.11%

iShares ESG Select Screened S&P Small-Cap ETF

0.1%

iShares Core S&P Small-Cap ETF

0.09%

State Street SPDR S&P Health Care Services ETF

占比2.38%

Invesco S&P SmallCap Health Care ETF

占比0.77%

First Trust Nasdaq Lux Digi Health Solutions ETF

占比0.5%

Inspire Small/Mid Cap ESG ETF

占比0.32%

iShares U.S. Healthcare Providers ETF

占比0.2%

Invesco S&P SmallCap 600 QVM Multi-factor ETF

占比0.14%

iShares S&P Small-Cap 600 Value ETF

占比0.12%

Nuveen ESG Small-Cap ETF

占比0.11%

iShares ESG Select Screened S&P Small-Cap ETF

占比0.1%

iShares Core S&P Small-Cap ETF

占比0.09%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

常见问题

Neogenomics Inc的前五大股东是谁？



Neogenomics Inc 的前五大股东如下：
BlackRock Institutional Trust Company, N.A.持有股份：17.77M，占总股份比例：13.76%。
The Vanguard Group, Inc.持有股份：14.10M，占总股份比例：10.92%。
First Light Asset Management, LLC持有股份：6.85M，占总股份比例：5.30%。
Greenhouse Funds LLLP持有股份：7.43M，占总股份比例：5.75%。
Millennium Management LLC持有股份：3.32M，占总股份比例：2.57%。